324.80MMarket Cap-3527P/E (TTM)
1.310High1.210Low1.12MVolume1.240Open1.220Pre Close1.43MTurnover0.66%Turnover RatioLossP/E (Static)255.75MShares2.05052wk High3.38P/B216.60MFloat Cap0.42052wk Low--Dividend TTM170.55MShs Float21.570Historical High--Div YieldTTM8.20%Amplitude0.420Historical Low1.274Avg Price1Lot Size
Adaptimmune Therapeutics Stock Forum
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$
come on
😩. I wish I had more capital. This is about to run hard.
Turnaround proxy after FDA approval.
The treatment or cure of cancer, will be a huge business.
$Adaptimmune Therapeutics (ADAP.US)$
No comment yet